Doubling Down on the PI3K-AKT-mTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness
Keyword(s):
Keyword(s):
2017 ◽
Vol 60
(23)
◽
pp. 9470-9489
◽
Keyword(s):
Keyword(s):
2010 ◽
2016 ◽
Keyword(s):
2020 ◽
pp. 1-13
◽
Keyword(s):
2015 ◽
Vol 92
(2)
◽
pp. 399-406
◽
Keyword(s):